Evidence map›Paper›PMID 36659948›Full record

ArticleInternational journal of ophthalmology2023

Visual perception alterations in COVID-19: a preliminary study.

María Begoña Coco-Martín, Luis Leal-Vega, Irene Alcoceba-Herrero, Ainhoa Molina-Martín, Dolores de-Fez, María José Luque, Carlos Dueñas-Gutiérrez, Juan Francisco Arenillas-Lara, David P Piñero

Open access · goldAbstract read
In one paragraph

Article in International journal of ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

María Begoña Coco-MartínGroup of Applied Clinical Neurosciences and Advanced Data Analysis, Department of Medicine, Dermatology and Toxicology, University of Valladolid, Valladolid 47005, Spain.
Luis Leal-VegaGroup of Applied Clinical Neurosciences and Advanced Data Analysis, Department of Medicine, Dermatology and Toxicology, University of Valladolid, Valladolid 47005, Spain.
Irene Alcoceba-HerreroGroup of Applied Clinical Neurosciences and Advanced Data Analysis, Department of Medicine, Dermatology and Toxicology, University of Valladolid, Valladolid 47005, Spain.
Ainhoa Molina-MartínGroup of Optics and Visual Perception, Department of Optics, Pharmacology and Anatomy, University of Alicante, Alicante 03690, Spain.
Dolores de-FezGroup of Optics and Visual Perception, Department of Optics, Pharmacology and Anatomy, University of Alicante, Alicante 03690, Spain.
María José LuqueDepartment of Optics, and Optometry and Vision Sciences, University of Valencia, Valencia 46100, Spain.
Carlos Dueñas-GutiérrezCOVID-19 Unit, Department of Internal Medicine, University Clinical Hospital of Valladolid, Valladolid 47003, Spain.
Juan Francisco Arenillas-LaraGroup of Applied Clinical Neurosciences and Advanced Data Analysis, Department of Medicine, Dermatology and Toxicology, University of Valladolid, Valladolid 47005, Spain.
David P PiñeroGroup of Optics and Visual Perception, Department of Optics, Pharmacology and Anatomy, University of Alicante, Alicante 03690, Spain.
Universidad de Valladolid · ESUniversity of Alicante · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo compare the visual perception (color and chromatic-achromatic contrast vision) of a small cohort of COVID-19 patients at the time of infection and after 6mo with that of a healthy population matched for sex and age.

methodsA total of 25 patients (9 females, 16 males, mean age: 54±10y) with COVID-19 hospitalized in the COVID-19 Unit of the University Clinical Hospital of Valladolid were recruited for this preliminary study. Visual perception, as determined by monocular measurement of contrast sensitivity function (CSF) and color vision was assessed in each patient using the Optopad test. The results obtained were then compared with those of a sample of 16 age- and sex-matched healthy controls (5 females, 11 males, mean age: 50±6y) in which the same measurement procedure was repeated. Statistically significant differences between groups were assessed using the Mann-Whitney

resultsDiscrimination thresholds (color and chromatic-achromatic contrast vision) and their corresponding sensitivity, calculated as the inverse of the discrimination threshold, were evaluated. Analysis of the data revealed higher contrast threshold results (

conclusionThe present results provide preliminary evidence that visual perception may be impaired in COVID-19, even when the infection has passed. Although further research is needed to determine the precise causes of this finding, analysis of CSF and color vision could provide valuable information on the visual impact of COVID-19.

Indexed as

color visioncontrast sensitivity functionCOVID-19SARS-CoV-2visual perception

Identifiers

PMID36659948
PMCPMC9815973
OpenAlexW4313230454

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.